Correlation between PLR and NLR with Tumor Size in Breast Cancer Patients
DOI:
https://doi.org/10.24293/ijcpml.v30i3.2199Keywords:
Breast cancer, PLR, NLR, tumor sizeAbstract
Breast cancer is the most common malignancy in females globally and one of the main causes of cancer death. There are several markers of cancer-related inflammation to help predict the relationship between pathologic characteristics of breast cancer. The research objective was to analyze the correlation between PLR and NLR with associated tumor size in breast cancer. This was a retrospective study with a cross-sectional design. This study used secondary data from the medical records of breast cancer patients who met the inclusion criteria at Siti Khodijah Hospital, Sidoarjo from January 2021 to March 2023. The sample size was 54 subjects, patients with breast cancer confirmed by pathology anatomy. The exclusion criteria were patients with infection, autoimmune disease, and hematology disorder. All the subjects were female. The mean age at the time of breast cancer diagnosis was 50.18±10.23 years, range of 27-80 years old. Most of the patients were over 50 years as much as 28 (51.85 %), while there were 26 (48.14%) > 50 years. The PLR range was 15.45-600.0, the NLR range was 0.58-9.98, tumor size range was 0.5-10.0 cm. Correlation between PLR and NLR with tumor size in breast cancer (p=0.351 and p=0.339). Correlation analysis showed that PLR and NLR had no significant correlation with tumor size ( r= -0.129, p=0.351 and r= -0.133, p=0.339). In conclusion, there is no significant correlation between PLR and NLR with histopathology of tumor size in patients with breast cancer.
Downloads
References
Takeuchi H, Kawanaka H, Fukuyama S, Kubo N, Hiroshige S, Yano T. Comparison of the prognostic values of preoperative inflammation-based parameters in patients with breast cancer. PLoS One, 2017; 12(5): e0177137,1-10.
Kim JY, Jung EJ, Kim JM, Lee HS, Kwag SJ, et al. Dynamic changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predicts breast cancer prognosis. BMC Cancer, 2020; 20(1): 1206.
Kanker payudara paling banyak di Indonesia, Kemenkes targetkan pemerataan layanan kesehatan. 2022. Available from: https://www.kemkes.go.id/article/view/22020400002/health- care-equality-for-breast-cancer-patients.html (accessed Feb 09, 2022).
Ami Ashariati. Buku managemen kanker payudara komprehensif. Surabaya, Interna Hematologi-Onkologi, 2019; 2.
Rivard AB, Galarza-Paez L, Peterson DC. Anatomy, thorax, breast. In StatPearls. StatPearls Publishing, 2022; 1-8.
Simanullang, Agnes ME. Validasi pemeriksaan ultrasoografi payudara terhadap pemeriksaan histopatologi untuk mendiagnosis kanker payudara di RSUD Dr. Pirngadi Kota Medan Tahun 2019-2020. 2022. Available from: https://repository.uhn.ac.id/bitstream/handle/123456789/6662/AGNES%20M.%20E%20SIMANULLANG.pdf?sequence=1&isAllowed=y (accessed April 12, 2022).
Satya Wangsa IGM, Niryana IW, Adiputra PAT, Arista Dewi NAP. Gambaran stadium dan jenis histopatologi ukuran tumor kanker payudara di Subbagian Bedah Onkologi RSUP Sanglah Denpasar tahun 2015-2016. Intisari Sains Medik, 2018; 80-84.
Guiliano AE, Edge SB, Hortobagyi GN, Connolly JL. AJCC cancer staging manual, breast. Eight Ed., Journal of the society of Surgical Oncology, 2018; 25: 1783-1785.
Lokuhetty Dilani, White VA, Watanabe R, Cree IA. WHO classification of tumors, breast tumor, 5th Ed., International Agency for Research of Cancer, 2019; 1-300.
Cho U, Park HS, Im SY, Yoo CY, Jung JH, Suh YJ, Choi HJ. Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer. PLoS One, 2018; 13(7): e0200936.
Zhang M, Huang XZ, Song YX, Gao P, Sun JX, et al. High platelet to lymphocyte ratio predicts poor prognosis and clinicopathological characteristics in patients with breast cancer: A meta-analysis. Hindawi Biomed Research International, 2017; ID9503025: 1-11.
Nurhayati, Zaenal Arifin H. Analisis faktor-faktor yang berhubungan dengan kejadian kanker payudara. Holistik J Kesehat, 2019; 13(2): 175–85.
Shimizu T, Taniguchi K, Asakuma M, Tomioka A, Inoue Y, et al. Lymphocyte-to-monocyte ratio and prognostic nutritional index predict poor prognosis in patients on chemotherapy for unresectable pancreatic cancer. Anticancer Research, 2019; 39(4): 2169–2176.
Fang T, Wang Y, Yin X, Zhai Z, Zhang Y, et al. Diagnostic sensitivity of NLR and PLR in early diagnosis of gastric cancer. Journal of Immunology Research, 2020; 9146042: 1-9.
Rönnau ADRO, Berto MD, Bica CG, Alves RV, Rotta LN. Platelet concentration and platelet/lymphocyte ratio as prognostic indicators in luminal breast cancer. Journal of Molecular Pathology, 2023; 4(1): 15–27.
Greten FR, Grivennikov SI. Inflammation and cancer: Triggers, mechanisms, and consequences. Immunity, 2019; 51(1): 27–41.
Sastroasmoro, Ismael. Dasar-dasar metodologi penelitian, Ed 5., Cetakan kedua, Jakarta, Sagung Seto, 2016; 1-522.
Yang L, Wang H, Ma J, Hao J, Zhang C, et al. Association between the platelet to lymphocyte ratio, neutrophil to lymphocyte ratio and axillary lymph node metastasis in cT1N0 breast cancer patients. American Journal of Translational Research, 2021; 13(3): 1854–1861.
Anwar SL, Cahyono R, Avanti WS, Budiman HY, Harahap WA, Aryandono T. Pre-treatment neutrophil-lymphocyte and platelet-lymphocyte ratios as additional markers for breast cancer progression: A retrospective cohort study. Annals of Medicine and Surgery, 2021; 2012(63): 102144.
Graziano V, Grassadonia A, Lezzi L, Vici P, Pizzuti L, et al. Combination of peripheral neutrophil to lymphocyte ratio and platelet to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients. The Breast, 2019; 44: 33-38.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
